The 'New' New Way To Sell Prescription Medications
Eli Lilly has launched LillyDirect, a direct-to-consumer platform for its weight-loss medications like Zepbound, bypassing traditional pharmacy benefit managers (PBMs). This integrated system includes online physician referrals and in-house pharmacy fulfillment, offering lower prices than PBMs and aiming to streamline the prescription process for patients. The move represents a significant shift in pharmaceutical sales, leveraging technology to create a more direct relationship with consumers and potentially challenging the established role of PBMs in the healthcare industry. AI
IMPACT This shift to direct-to-consumer sales and integrated software platforms by pharmaceutical companies may accelerate the adoption of AI in healthcare for patient management and prescription fulfillment.